Abstract-Schizophrenia is a common psychotic disorder, with a risk of about 1%, the aetiology of schizophrenia unknown, one of which includes immunological disorders. Although, there are conflicting results, most studies focusing on plasma levels or the production of mitogen-stimulated cytokines, such as tumor necrosis factor. This study compared serum levels of Tumor necrosis factor alpha in male chronic schizophrenic patients and healthy control, and the correlation with severity of illness. This study was conducted on 40 male patients diagnosed with chronic schizophrenic and 40 healthy control. Severity illness was assessed with Positive and Negative Syndrome Scale. Serum levels of Tumor necrosis factor alpha were measured by immunossay. Tumor necrosis factor alpha levels were significantly higher in male patients with chronic schizophrenic to healthy control subjects. Correlation analysis revealed a significant positive correlation between the serum levels of Tumor necrosis factor alpha and the Positive and Negative Syndrome Scale total score. This study suggest that Tumor necrosis factor alpha may be involved in the psychopathology of schizophrenia and may be a marker of schizophrenia.
I. INTRODUCTION Schizophrenia is a common psychotic disorder, with a risk of about 1%, the most common early onset of this disease is 15-30 years of age, and is a chronic disease that causes disruption to patients and their families [1] . The exact cause of schizophrenia is not known, although several aetiological theories have been proposed for the disease, including developmental or neurodegenerative processes, neurotransmitter abnormalities, viral infection and immune dysfunction or autoimmune mechanisms [2] . Schizophrenic patients have aberrant proportions of immuno-competent cells and varied levels of cytokines, especially proinflammatory interleukin (IL)-6, IL-1 and tumour necrosis factor (TNF)-α , in their peripheral blood or cerebrospinal fluid [3] . Cytokines function as chemical messengers between immune cells and have numerous important functions in immune regulation. They also play a critical role in infectious and inflammatory processes by mediating the cross-talk between the brain and the immune system, which has been a recent focus of immunologic research in schizophrenia [4] . TNF-α production by schizophrenic patients was significantly higher than by normal controls [5, 6] . In contrast to study conducted by Lv in Beijing in 2012 reported that TNF-α levels were significantly lower in patients with chronic schizophrenia relative to healthy control subjects (p<0.01). Correlation analysis revealed a significant negative correlation between the TNF-α levels and the PANSS total score (p<0.01) [7] . Therefore, this study is interested to determine whether there are differences in serum TNF-α in male patients with chronic schizophrenic and healthy control and correlation with severity illness.
II. METHODS A. Data Source and sample
This study was an unpaired numerical comparative analysis, used cross-sectional study, divided in two groups: male patients with chronic schizophrenic and healthy control group and the correlation with severity illness. Among psychiatric patients admitted in wards of the Prof. Dr. M. Ildrem Hospital, North Sumatera, Indonesia, during September 2016 to February 2017, we recruited fourty schizophrenic patients. All patients had chronic schizophrenic patients in stabilization phase of treatment at the time of study enrollment. All patients had been medication risperidone 4mg, heavy smokers, age 20-40 years old, Body Mass Index (BMI) score 18.50 -24.99 kg/m2, understand the Indonesian language and willing to be a respondent and can be interviewed. Patients with a history of any concomitant psychiatric illness, such as substance or alcohol abuse, a history of chronic and acute physical condition (such as infectious or allergic diseases) associated with abnormal cell-mediated immunity or a known autoimmune disease were excluded. Fourty controls were recruited at the same hospital in the same hospital among employees, nurses and other medical personnel who working there and caregivers who come to check-up their families. Age, heavy smokers and Body Mass Index (BMI) were matched between schizophrenia patients and healthy controls. Each healthy control with any personal or familial history of psychiatric illness, diagnosed autoimmune disease, chronic and acute physical illness (such as infectious or allergic diseases) associated with abnormal cell-mediated immunity, or substance or alcohol abuse were excluded. The patients gave informed consent after the procedure had been fully explained. This study was approved by the Institutional Ethical Committee of University of Sumatera Utara.
B. Measures
Male who reported having been diagnosed with chronic schizophrenic by a psychiatrist; therefore, for the purposes of this study, the definition of schizophrenic is a chronic schizophrenic patient in the stabilization phase of treatment [8, 9] . Schizophrenic patients assessed by using International Statistical Classification of Diseases and Related Health Problems -10 (ICD-10) [10] .
The severity of illness was assessed using the Positive and Negative Syndrome Scale (PANSS), that is determined from the total scores PANSS to reflect burden of illness [11] .
Tumor necrosis factor alpha (TNF -α) also known as cachectin, is the prototypic ligand of the TNF superfamily. It is a pleiotropic molecule that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism. In this study, serum TNFα levels were measured by Quantikine HS Human TNF-α Immunoassay which is a 6.5 hour solid phase ELISA designed to measure TNF-α in serum and plasma [12] .
C. Covariates
Sociodemographic characteristics included age, marital status was coded into two catogories (Married or Unmarried), educational level education was categorized as junior high school, senior high school, and college, and ethnic group was categorized Bataknese or Non Bataknese. Chronic and acute physical condition assessed by the health interview (such as infectious or allergic diseases). Heavy smokers was defined status of smoking exposure (>20 cigarettes daily) [13] . Body mass Index (BMI) was calculated using measurements of subjects weight and height [weight (kg)/height (m 2 )]. Normal was considered present if subjects had a BMI of 18.50 -24,99 kg/m 2 [14] .
D. Statistical Analysis
Serum levels of TNF-α s in both groups were analyzed using unpaired T test , If the serum levels of TNF-α were normally distributed both in schizophrenic patients and controls (Saphiro-Wilk test, p>0.05). The significance level was set at p<0.05 for all analysis. The correlation of serum levels of TNF-α with severity of illness was analyzed by using Pearson correlation test with the condition that the data for both serum levels of TNF-α variables and the total PANSS score were normally distributed, If not normally distributed, data will be analyzed by using Spearman correlation test [15] .
III. RESULTS A. Sociodemographic Characteristics
In this study recruiting 80 male subjects, and divided into two groups: 40 subject had been diagnosed with chronic schizophrenic by psychiatrist, And 40 subjects as healthy control group. The mean age in the schizophrenic group (33.80±3.51), and control group (34.43±3.59). Based on marital status, the schizophrenic group married 27 (21.60%) more than unmarried subjects, and healthy control group the most was married subject 24 (19.20%). In both the schizophrenic group and healthy control group the most was Bataknese ethnic group. The mean body mass index in the schizophrenic group was 21.61±2.01, and healthy control group was 21.13±1.86. There were no significant differences in age, marital status, ethnic group, and BMI between the groups (both p>0.05).
In schizophrenic group, highest level of education is junior high school (47.50%) and in healthy group is collage (42.50%). There were significant differences in education (p<0.05), but education did not significantly affect of serum levels of TNF-α. 
B. Comparison Serum Levels of Tumor Necrosis Factor Alpha (TNF-α) in Male Patients with Chronic Schizophrenic Versus Healthy Control
All Serum levels of TNF-α in male patients with chronic schizophrenic (25.12±1.76) was significantly higher than healthy controls group (5.48±1.68), by using independent T test, there were significant difference between the mean TNF-α between the schizophrenic and healthy control groups (p=0.001; p<0.05). 
C. Correlations between Serum Levels of Tumor Necrosis Factor Alpha (TNF-α) and Severity of Illness in Schizophrenia
The correlation of serum levels of TNF-α with severity of the disease was analyzed using Spearman correlation test, because for both serum levels of TNF-α variables and the total PANSS score were not normally distributed. Serum levels of TNF-α were significantly positively correlated with the PANSS total score (r= 0.723, p<0.001, n=40). 
*Spearman correlation test
IV. DISCUSSION The main findings of the present study were that serum levels of TNF-α level was significantly higher in male patients with chronic schizophrenia than in healthy control subjects, and there were significantly positive correlations between serum levels of TNF-α and the total PANSS score. We demonstrated that pro inflammatory cytokines TNF-α were significantly higher in schizophrenic patients as compared to healthy controls. These results are consistent with some previous studies that showed higher production of TNF-α levels in schizophrenic patients. Miller et al. and Potvin et al. reported that Increation of serum levels of TNF-α alpha is reciprocal with the well-described pro-inflammatory state in schizophrenia. Increased TNF-α are proinflammatory mediators produced predominantly by macrophages [16, 17] . Several studies have proved increased plasma cytokine levels or mitogen-stimulated cytokine production in schizophrenia such as TNF-α [18] .
Increased plasma levels of TNF associated with schizophrenia is also confirmed by Na et al. in Korea and Theodoropoulou et al. in Athens shows the levels of TNF-α were significantly higher in chronic schizophrenic patients compared with healthy controls (p <0.001). [5, 6] Kubistova et al. measuring elevated serum levels of TNF-α in schizophrenic and healthy controls pre and post treatment found significant differences in serum levels of TNF-α were higher in the schizophrenic group compared with controls both before and after treatment. significant correlation between PANSS subscales for positive and negative subscales and the total PANSS score or between the differences in psychopathology and cytokine levels before and after treatment [19] . Al-Asmari observed serum levels of TNF-α of schizophrenic patients were significantly higher than those of healthy controls. The different activities of inflammatory cytokines in schizophrenic patients suggest that specific subtypes of cytokines, monocytic proinflammatory cytokines,may be associated with the immunopathogenesis of schizophrenia [20] . Ajami et al. reported serum levels TNF-α in schizophrenic higher than healthy control. They concluded an increase in TNF-α may have an important role in schizophrenic psychopathology [21] .
In contrast with Zhang et al. measuring cytokine levels including TNF-α in chronic schizophrenic patients who smoked with long-term antipsychotic use found no significant difference in serum levels of TNF-α in chronic schizophrenic patients who smoked (10.1 ± 1.8) and non smoke (10.7 ± 2.7) p=0.28. Nevertheless they argue in accordance with previous studies that schizophrenia is characterized by activation of proinflammatory cytokines such as TNF-α [22] . TNF-α is a cytokine involved in systemic inflammation and is a member of a group of cytokines which stimulate acute phase reactions . A chronic immune activation in schizophrenia have been shown elsewhere [23] . TNF-α is a ubiquitous pro-inflammatory cytokine elevated in immune response. TNF-α might contribute to the pathogenesis of schizophrenia by activation of the hypothalamo-pituitary-adrenocortical (HPA) axis, activation of neuronal serotonin transporters, stimulation of the indoleamine 2,3-dioxygenase which leads to tryptophan depletion and activation of kynurenine metabolites, or by neurotoxic release of glutamate [24] . In addition, cytokines might cross the blood-brain barrier (BBB) either through leaky areas or by active transport. Increased permeability of the BBB may enable activated immune or neurotoxic cytokines to enter the CNS and trigger psychopathological changes [20] .
V. CONCLUSIONS This study suggest that TNF-α maybe play important roles in the pathophysiology of schizophrenia and may be a marker of schizophrenia. There is a growing evidence base supporting the role of inflammation in the etiology of schizophrenia. TNF-α might contribute to the pathogenesis of schizophrenia by activation of the HPA axis, activation of neuronal serotonin transporters, stimulation of the indoleamine 2,3-dioxygenase which leads to tryptophan depletion and activation of kynurenine metabolites, or by neurotoxic release of glutamate and cytokines might cross the blood-brain barrier (BBB). Although, many studies report immunological findings in schizophrenia but are still often contradictory. Variables that may be confounding in studies are important for control, including disease length, treatment received, comorbidities and additional factors that may be biased variables. So the evidence that changes in cytokine levels occur in schizophrenia is still needed.
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